ALXO
USDALX Oncology Holdings Inc. Common Stock
$1.460-0.060 (-3.947%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$1.520
Haut
$1.600
Bas
$1.460
Volume
0.54M
Fondamentaux de l'Entreprise
Capitalisation Boursière
78.2M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.93M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Bas $0.404Actuel $1.460Haut $2.27
Actualités Connexes
GlobeNewswire
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of
Voir plus
GlobeNewswire
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical data supports
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.